Nicole E Smolinski, Pharm.D., Ph.D.
Research Assistant Professor
Department:
Pharmaceutical Outcomes & Policy
Business Email:
nsmolinski@ufl.edu
About Nicole E Smolinski
Nicole is a research assistant professor in POP working with Dr. Almut Winterstein. She earned two bachelor’s degrees in child psychology and chemistry from the University of Minnesota in 2015. She then received her Pharm.D. from Midwestern University in 2019. She finished her Ph.D. from the University of Florida in 2024. Her research focuses on child and maternal health with a special interest in pediatric acute otitis media. Her dissertation focused on acute otitis media, treatment preference, and complications. She has also worked on multiple pregnancy-related projects focuses on the safety of medications during pregnancy.
Accomplishments
DuBow Graduate Student Fellowship
2019
·
University of Florida
Research Profile
Areas of Interest
- Infectious diseases
- Maternal and Child Health
- Pediatrics
Publications
Academic Articles
2024
Antibiotic treatment to prevent pediatric acute otitis media infectious complications: A meta-analysis.
PloS one.
19(6)
[DOI] 10.1371/journal.pone.0304742.
[PMID] 38885271.
2024
Antihypertensive utilization patterns among pregnant persons with pre-existing hypertension in the US: A population-based study.
PloS one.
19(7)
[DOI] 10.1371/journal.pone.0306547.
[PMID] 38959230.
2024
Common teratogenic medication exposures-a population-based study of pregnancies in the United States.
American journal of obstetrics & gynecology MFM.
6(1)
[DOI] 10.1016/j.ajogmf.2023.101245.
[PMID] 38061552.
2024
Development and Validation of an Algorithm to Predict Stillbirth Gestational Age in Medicaid Billing Records.
American journal of epidemiology.
[DOI] 10.1093/aje/kwae369.
[PMID] 39307537.
2024
Prenatal Care Initiation and Exposure to Teratogenic Medications.
JAMA network open.
7(2)
[DOI] 10.1001/jamanetworkopen.2023.54298.
[PMID] 38300617.
2024
Prenatal Exposure to Valproic Acid Across Various Indications for Use.
JAMA network open.
7(5)
[DOI] 10.1001/jamanetworkopen.2024.12680.
[PMID] 38776082.
2024
Teratogenic Risk Impact and Mitigation (TRIM): Study Protocol for the Development of a Decision Support Tool to Prioritize Medications for Risk Mitigation.
Drug safety.
[DOI] 10.1007/s40264-024-01488-4.
[PMID] 39499480.
2023
IMPACT OF CONTINUOUS MATERNAL ENROLLMENT ON STILLBIRTH GESTATIONAL AGE DISTRIBUTIONS AND MATERNAL CHARACTERISTICS AMONG MEDICAID ENROLLEES.
American journal of epidemiology.
192(3):497-502
[DOI] 10.1093/aje/kwac206.
[PMID] 36482740.
2023
Protocol of a Combined Cohort and Cross-Sectional Study of Persons Receiving Medical Cannabis in Florida, USA: The Medical Marijuana and Me (M3) Study.
Medical cannabis and cannabinoids.
6(1):46-57
[DOI] 10.1159/000530052.
[PMID] 37261066.
2023
Trends in Prescribing of Non-steroidal Anti-inflammatory Medications in the US Ambulatory Care Setting From 2006 to 2016.
The journal of pain.
24(11):1994-2002
[DOI] 10.1016/j.jpain.2023.06.008.
[PMID] 37330160.
2023
Validation of an ICD-9-Based Algorithm to Identify Stillbirth Episodes from Medicaid Claims Data.
Drug safety.
46(5):457-465
[DOI] 10.1007/s40264-023-01287-3.
[PMID] 37043168.
2022
Prenatal exposure to teratogenic medications in the era of Risk Evaluation and Mitigation Strategies.
American journal of obstetrics and gynecology.
227(2):263.e1-263.e38
[DOI] 10.1016/j.ajog.2022.01.004.
[PMID] 35032444.
2022
Proceedings of the 2022 Cannabis Clinical Outcomes Research Conference.
Medical cannabis and cannabinoids.
5(1):138-141
[DOI] 10.1159/000527080.
[PMID] 36467782.
2022
Risk of fetal/neonatal death or neonatal intensive care unit admission associated with gadolinium magnetic resonance imaging exposure during pregnancy.
American journal of obstetrics and gynecology.
228(4):465.e1-465.e11
[DOI] 10.1016/j.ajog.2022.10.005.
[PMID] 36241080.
2022
Watchful Waiting for Acute Otitis Media.
Pediatrics.
150(1)
[DOI] 10.1542/peds.2021-055613.
[PMID] 35726560.
Presentations
2021-08-23
Gender Differences in Valproic Acid Use for Approved Indications in the United States (2017-2018) – an opportunity for risk mitigation?
International
/
Other.
Poster.
Education
PhD
2019-2024
·
University of Florida
Pharm.D.
2015-2019
·
Midwestern University- Downers Grove
B.S. Child Psychology, B.A. Chemistry
2011-2015
·
University of Minnesota- Twin Cities
Contact Details
Emails:
- Business:
- nsmolinski@ufl.edu
Addresses:
- Business Mailing:
-
PO Box 100496
GAINESVILLE FL 32610 - Business Street:
-
1889 MUSEUM RD STE 6300
GAINESVILLE FL 32611